Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

Market Cap	9.34B -29.9%
Revenue (ttm)	2.72B -8.7%
Net Income	279.33M -40.3%
EPS	1.21 -40.0%
Shares Out	226.01M
PE Ratio	18.16
Forward PE	n/a
Dividend	1.15 (5.24%)
Ex-Dividend Date	n/a

Volume	113,300
Average Volume	167,548
Open	21.88
Previous Close	21.88
Day's Range	21.68 - 21.88
52-Week Range	21.68 - 31.28
Beta	0.59
RSI	34.43
Earnings Date	Mar 20, 2026

About HKG:6826

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,156
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6826

Financial Performance

In 2025, HKG:6826's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.

Financial numbers in CNY